Clinical Trial Update: An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for PF-03715455 in moderate to severe uncontrolled asthma has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PF-03715455

Snippet

Sponsor: Pfizer | Conditions: Asthma | Phase 2 | Status: TERMINATED | Results posted: 2019-06-12